Skip to main content
Clinical Trials/NCT03737578
NCT03737578
Unknown
Not Applicable

Efficacy of Daily Hemodialysis Compared With in Center Hemodialysis 3 Times Per Week

Physidia1 site in 1 country160 target enrollmentJune 27, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
End Stage Renal Disease
Sponsor
Physidia
Enrollment
160
Locations
1
Primary Endpoint
Physical activity of patients (total average number of steps taken per day through connected pedometer/accelerometer)
Last Updated
6 years ago

Overview

Brief Summary

The objective of this study is to describe the characteristics of patients on daily home hemodialysis and to confirm in real practice in France the effectiveness shown in studies, mainly American, both in terms of clinical outcomes and quality of life. Due to the few studies available in this population, the focus will be particularly on physical activity.

Detailed Description

Primary objective : The main objective of this study is to evaluate the physical activity in the daily life of patients in daily hemodialysis in comparison with patients treated 3 times a week (conventional hemodialysis) others objectives are also: 1. To describe the characteristics of daily hemodialysis patients; 2. To describe the prescription procedures of the home daily HD; 3. To compare the evolution of the blood pressure between the 2 modalities of hemodialysis; 4. To compare the frequency of hospitalizations, duration and hospitalization reasons between the 2 hemodialysis modalities; 5. To compare the quality of life of the patients between the 2 modalities ; 6. To evaluate the quality of the sleep of the patients between the 2 modalities ; 7. Compare the percentage of patients with restless leg syndrome (RLS) and the severity of RLS between the two modalities; 8. Compare the evolution of drug intake between the two modalities; 9. Evaluate the number of abandoning subjects and causes of discontinuation of HQD;

Registry
clinicaltrials.gov
Start Date
June 27, 2018
End Date
June 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Physidia
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female aged 18 years or over
  • Patient who dated and signed the consent form
  • Patient (s) affiliated to a Social Security scheme
  • Interventional arm: patient who begins or will begin daily hemodialysis training (5, 6 or 7 times per week) at home.
  • Comparator arm: prevalent or incident patient treated by conventional hemodialysis (3 times per week) and fitting with the matching criteria of an interventional patient included in the center

Exclusion Criteria

  • Patient with needs any help to walk (wheelchair, crutch, walker, cane ...)
  • Patient with active neoplasia;
  • Patient with predicted life expectancy of less than one year;
  • Patient with significant reading or writing difficulties;
  • Patient participating in a clinical trial or other interventional study;
  • Patient with history of mental instability, major cognitive impairment in the previous 5 years, or major psychiatric condition not adequately controlled or stable under pharmacological treatment

Outcomes

Primary Outcomes

Physical activity of patients (total average number of steps taken per day through connected pedometer/accelerometer)

Time Frame: 12 months

The main criteria is the total average number of steps taken per day

Secondary Outcomes

  • Evolution of the frequency of hospitalizations during the study period(During visit at month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12)
  • Change in quality of the sleep of the patients through questionnaire during the study period(At inclusion and during visit at month 3, 6, 9 and 12)
  • Change of drug intake during the study period (posology of drugs linked with ESRD)(During visit at month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12)
  • Evolution of the blood pressure during the study period(At inclusion and during visit at month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12)
  • Change in quality of life of the patients measured through questionnaire during the study period(At inclusion and during visit at month 3, 6, 9 and 12)
  • Change of the percentage of patients with restless leg syndrome (RLS) during the study period(At inclusion and during visit at month 3, 6, 9 and 12)

Study Sites (1)

Loading locations...

Similar Trials